Dr Dionysis Papadatos-Pastos is a London based oncologist with a specialist interest in lung cancer, mesothelioma and thymic tumors. He is the lead for lung cancer in the CRUK UCL Clinical Trials Centre and the joint lead for oncology at The Princess Alexandra NHS Hospital.
Throughout his career, he has gained extensive experience in cancer management using treatments such as immunotherapy, targeted therapies, and chemotherapy.
He graduated in medicine from the University of Athens with distinction, which was followed by his PhD in medical oncology in 2012 with First Class honours. He trained in medical oncology in prestigious hospitals including The Royal Marsden, St George’s University Hospitals, and Guy’s and St Thomas’. He was awarded a diploma in medical oncology from the Institute of Cancer Research at the University of London.
Dr Papadatos-Pastos is an avid researcher and has been the principal investigator on multiple academic and commercial clinical trials. He has a strong interest in early drug development. He has also presented at conferences, nationally and worldwide. His topics of research include the development of novel targeted therapies for the treatment of lung cancer, and assessing combinations of immunotherapy drugs with other anti-cancer compounds. Furthermore, he has been widely published in scientific medical journals and peer-reviewed papers.
NHS Base
University College London Hospitals NHS Foundation Trust, The Princess Alexandra Hospital NHS Trust